Puissant H - Search Results

1

Very low alpha-fetoprotein in Down syndrome maternal serum screening.

Muller F, Dreux S, Sault C, Galland A, Puissant H, Couplet G, Lemay C, Larcher ME, Renom G; ABA Group. Muller F, et al. Among authors: puissant h. Prenat Diagn. 2003 Jul;23(7):584-7. doi: 10.1002/pd.646. Prenat Diagn. 2003. PMID: 12868089

2

[Down syndrome maternal serum screening: results' comments recommended by accredited biologists].

Muller F, Dreux S, Czerkiewicz I, Bernard M, Guibourdenche J, Lacroix I, Moineau MP, Read MH, Sault C, Thibaud D, Veyrat B; ABA; Bidat L. Muller F, et al. J Gynecol Obstet Biol Reprod (Paris). 2014 Nov;43(9):671-9. doi: 10.1016/j.jgyn.2014.05.012. Epub 2014 Sep 11. J Gynecol Obstet Biol Reprod (Paris). 2014. PMID: 25218268 French.

3

Association between altered placental human chorionic gonadotrophin (hCG) production and the occurrence of cryptorchidism: a retrospective study.

Chedane C, Puissant H, Weil D, Rouleau S, Coutant R. Chedane C, et al. Among authors: puissant h. BMC Pediatr. 2014 Jul 26;14:191. doi: 10.1186/1471-2431-14-191. BMC Pediatr. 2014. PMID: 25064170 Free PMC article.

4

Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study.

Dreux S, Nguyen C, Czerkiewicz I, Schmitz T, Azria E, Fouré MA, Muller F; ABA Study Group. Dreux S, et al. Am J Obstet Gynecol. 2013 May;208(5):397.e1-5. doi: 10.1016/j.ajog.2013.01.039. Epub 2013 Jan 24. Am J Obstet Gynecol. 2013. PMID: 23353023

5

Second-trimester maternal serum markers and placenta accreta.

Dreux S, Salomon LJ, Muller F, Goffinet F, Oury JF; ABA Study Group; Sentilhes L. Dreux S, et al. Prenat Diagn. 2012 Oct;32(10):1010-2. doi: 10.1002/pd.3932. Epub 2012 Jun 25. Prenat Diagn. 2012. PMID: 22729439 No abstract available.

6

Novel molecular diagnostic approaches for X-linked centronuclear (myotubular) myopathy reveal intronic mutations.

Tosch V, Vasli N, Kretz C, Nicot AS, Gasnier C, Dondaine N, Oriot D, Barth M, Puissant H, Romero NB, Bönnemann CG, Heller B, Duval G, Biancalana V, Laporte J. Tosch V, et al. Among authors: puissant h. Neuromuscul Disord. 2010 Jun;20(6):375-81. doi: 10.1016/j.nmd.2010.03.015. Neuromuscul Disord. 2010. PMID: 20434914

7

Mucopolysaccharidosis type IIID: 12 new patients and 15 novel mutations.

Valstar MJ, Bertoli-Avella AM, Wessels MW, Ruijter GJ, de Graaf B, Olmer R, Elfferich P, Neijs S, Kariminejad R, Suheyl Ezgü F, Tokatli A, Czartoryska B, Bosschaart AN, van den Bos-Terpstra F, Puissant H, Bürger F, Omran H, Eckert D, Filocamo M, Simeonov E, Willems PJ, Wevers RA, Niermeijer MF, Halley DJ, Poorthuis BJ, van Diggelen OP. Valstar MJ, et al. Among authors: puissant h. Hum Mutat. 2010 May;31(5):E1348-60. doi: 10.1002/humu.21234. Hum Mutat. 2010. PMID: 20232353

8

Molecular analysis of 53 fragile X families with the probe StB12.3.

Puissant H, Malinge MC, Larget-Piet A, Martin D, Chauveau P, Odent S, Plessis G, Parent P, Lemarec B, Larget-Piet L. Puissant H, et al. Am J Med Genet. 1994 Dec 1;53(4):370-3. doi: 10.1002/ajmg.1320530413. Am J Med Genet. 1994. PMID: 7864047

9

[Direct diagnosis of predominant mutation delta F508 associated with the mucoviscidosis gene].

Férec C, Guillermit H, Verlingue C, Parent P, Puissant H, Jehanne M, Saleun JP. Férec C, et al. Among authors: puissant h. Arch Fr Pediatr. 1990 Aug-Sep;47(7):507-10. Arch Fr Pediatr. 1990. PMID: 2256790 French.

10

Multibranched chromosomes in the ICF syndrome: immunodeficiency, centromeric instability, and facial anomalies.

Turleau C, Cabanis MO, Girault D, Ledeist F, Mettey R, Puissant H, Prieur M, de Grouchy J. Turleau C, et al. Among authors: puissant h. Am J Med Genet. 1989 Mar;32(3):420-4. doi: 10.1002/ajmg.1320320331. Am J Med Genet. 1989. PMID: 2729362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page